Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

IBBvsPBEETF Comparison

ETF 1
IBB

iShares Biotechnology ETF

This fund is part of
US Health Care
-0.03%
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.14%

iShares Biotechnology ETF (IBB) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. IBB is less expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.58% for PBE. IBB is up 0.16% year-to-date (YTD) with -$327M in YTD flows. PBE performs worse with -3.02% YTD performance, and -$4M in YTD flows. Run a side-by-side ETF comparison of IBB and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IBB vs PBE performance and flow charts

Performance

0246810%Mar 27Apr 6Apr 13Apr 20Apr 27

Cumulative Flows

-100 M-50 M0 M50 M100 MMar 27Apr 6Apr 13Apr 20Apr 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/27/2026
1M3MYTD1Y3Y5Y
Perf.
IBB
PBE
+5.31%+3.54%
-4.45%-3.31%
+0.16%-3.02%
+35.85%+30.84%
+31.87%+28.68%
+8.56%+4.30%
Flows
IBB
PBE
-$138M+$18K
-$331M-$8M
-$327M-$4M
+$772M-$32M
-$1.59B-$60M
-$2.08B-$44M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IBB
PBE
+22.34%+19.47%
+21.20%+19.83%
+19.78%+20.12%
+22.09%+22.54%
Max drawdown
IBB
PBE
-9.27%-9.36%
-9.61%-11.70%
-24.82%-22.21%
-39.75%-34.74%
Max drawdown duration
IBB
PBE
90d79d
95d111d
377d324d
1611d1540d
Trading data

Create an account to view trading data

Join for free
IBB
PBE
Last sale
4/29/2026 at 1:30 PM
$165.38
$78.51
Previous close
04/28/2026
$167.81
$79.56
Consolidated volume
04/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IBB
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/29/2026 at 1:30 PM
Live
Closed
IBB
PBE
Last price
$165.38
$78.51
1D performance
-1.45%
-1.32%
AuM$8.03 B$247.37 M
E/R0.44%0.58%
Characteristics
IBB
PBE
Management strategyPassivePassive
ProvideriSharesInvesco
BenchmarkICE Biotechnology IndexDynamic Biotech & Genome Intellidex Index
N° of holdings17930
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateFebruary 5, 2001June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

IBB
USA
95.97%
Other
4.03%
PBE
USA
92.18%
Other
7.82%

Sectors

IBB
Health Care
85.68%
Other
14.32%
PBE
Health Care
97.59%
Other
2.41%
Advertisement

Diversification

IBB

Total weight of top 15 holdings out of 15

55.88%
PBE

Total weight of top 15 holdings out of 15

63.66%

Top 15 holdings

Data as of March 31, 2026
IBB
GILEAD SCIENCES
7.75%
AMGEN-T
7.51%
VERTEX PHARMACEUTICALS
7.44%
REGENERON PHARMACEUTICALS
7.21%
ALNYLAM PHARMACEUTICALS
3.99%
INSMED
3.20%
US04016X1019
3.07%
BIOGEN INC
2.46%
NATERA
2.41%
UTD THERAPEUT
2.30%
US07725L1026
1.93%
INCYTE
1.70%
MODERNA INC
1.68%
ILLUMINA
1.68%
REVOLUTION MEDICINES INC
1.54%
PBE
UTD THERAPEUT
6.05%
ILLUMINA
5.24%
REGENERON PHARMACEUTICALS
5.23%
ALNYLAM PHARMACEUTICALS
5.22%
BIOGEN INC
5.16%
AMGEN-T
4.99%
GILEAD SCIENCES
4.98%
INCYTE
4.89%
BIOCRYST PHARMACEUTICALS
3.66%
PROTAGONIST THERAPEUTICS INC
3.38%
TG THERAPEUTICS
3.11%
ROYALTY PHARMA
3.05%
NEUROCRINE BIOSCIENCES
2.93%
CATALYST PHARMACEUTICALS INC
2.89%
PTC THERAPEUTI/D
2.86%
Frequently asked questions about IBB and PBE

How have the IBB and PBE ETFs performed in 2026?

As of April 27, 2026, IBB is up 0.16% year-to-date (YTD), while PBE has lost -3.02%. That puts IBB better performer ahead so far this year.

Which ETF is attracting more investor money: IBB or PBE?

Year-to-date, the IBB ETF saw -$327M in flows, compared to -$4M for PBE.

Which ETF is more volatile: IBB or PBE?

Over the past year, IBB had a volatility of 21.2%, while PBE experienced 19.83%.

Which ETF is bigger: IBB or PBE?

As of April 27, 2026, IBB holds $8.03 B in assets under management (AUM), while PBE manages $247.37 M.

What sectors do the IBB and PBE ETFs invest in?

IBB leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the IBB ETF and PBE ETF?

IBB top holdings include GILEAD SCIENCES, AMGEN-T and VERTEX PHARMACEUTICALS. PBE holds in its top three: UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS.

Which ETF is more diversified: IBB or PBE?

IBB holds 249 securities with 55.88% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 63.66%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up